Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - STOCK-BASED COMPENSATION
Stock-based Compensation CHRS - Coherus BioSciences, Inc.
43.1 M
LAST VALUE
-8.39%
2 YEAR CAGR
4.38%
5 YEAR CAGR
35.64%
10 YEAR CAGR